A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS
Clinical trial NCT03319732 · COMPLETED
Trial details
- NCT number
- NCT03319732
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-03
- Primary completion
- 2020-01-27
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.